ENVB - Enveric Biosciences, Inc.
1.98
-0.110 -5.556%
Share volume: 92,329
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$2.09
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 03-28-2025 | 05-14-2025 | 08-14-2025 | 11-14-2025 | |
| Cash flow financing | 6.658 M | 34.430 K | 517.687 K | 463.448 K | 4.449 M | 449.096 K | 2.992 M | |
| Other financing cash flows | 2.677 M | 0.000 | 0.000 | 0.000 | 75.044 K | 0.000 | 1.934 M | |
| Cash flow | 4.060 M | 0.000 | 0.000 | 0.000 | 2.057 M | 0.000 | 0.000 | |
| Net income | -2.457 M | -1.879 M | -2.084 M | -3.155 M | -2.185 M | -2.519 M | -1.874 M | |
| Depreciation | 43.221 K | 42.591 K | 42.626 K | 40.301 K | 38.842 K | 39.982 K | 40.369 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 4.068 M | -2.853 M | -390.868 K | -870.657 K | 2.053 M | -1.445 M | 907.778 K |